Management options in the sudden hearing loss of a diabetic patient [PDF]
, 2019 The aim of our paper is to highlight the main therapeutic principles and the management options in the case of a diabetic patient who has had a sudden hearing loss.
Badiu, Dumitru Cristinel +11 more
core +3 more sources
Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy [PDF]
arXiv, 2018 Diabetic-induced peripheral neuropathy (DPN) is a diabetic late complication. The molecular mechanisms underlying the pathophysiology of nerve damage & sensory loss remain largely unclear. Recently, alterations in metabolic flux have gained attention a basis for organ damage in diabetes; however, peripheral sensory neurons have not been adequately ...
arxiv
Brain : a journal of neurology, 2012 Diabetic lumbosacral radiculoplexus neuropathy is a subacute painful, asymmetrical lower limb neuropathy due to ischaemic injury and microvasculitis. The occurrence of a cervical diabetic radiculoplexus neuropathy has been postulated.
R. Massie +7 more
semanticscholar +1 more source
Comparison of efficacy and tolerability of Duloxetine vs. Gabapentin in treatment of diabetic peripheral neuropathic pain [PDF]
, 2011 Introduction: Diabetic peripheral neuropathy (DPN) is one of the most common symptomatic, long-term complications in patients with both type 1 and type 2 diabetes mellitus, and most common and most debilitating of the diabetic neuropathies. Duloxetine,
Kalantar Hormozi, Mohamadreza +3 more
core
Corneal nerve fractal dimension: a novel corneal nerve metric for the diagnosis of diabetic sensorimotor polyneuropathy [PDF]
, 2018 Objective: Corneal confocal microscopy (CCM), an in vivo ophthalmic imaging modality, is a noninvasive and objective imaging biomarker for identifying small nerve fiber damage.
Alam, Uazman +10 more
core +2 more sources
Diabetic somatic neuropathies.
Diabetes Care, 2004 ropathic pain (7–10), and this and other putative mechanisms will be discussed. The clinical features, diagnosis, and management of the focal and multifocal neuropathies will be described. A major portion of this review will discuss the clinical features,
A. Boulton +3 more
semanticscholar +1 more source
Toxic and drug-induced peripheral neuropathies: updates on causes, mechanisms and management. [PDF]
, 2013 PURPOSE OF REVIEW: This review discusses publications highlighting current research on toxic, chemotherapy-induced peripheral neuropathies (CIPNs), and drug-induced peripheral neuropathies (DIPNs).
Buclin, T., Diezi, M., Kuntzer, T.
core +1 more source
Diabetic peripheral neuropathies.
Annals of Internal Medicine, 2010 Diabetic peripheral neuropathies are a group of heterogeneous syndromes with considerable morbidity. At least 50% of diabetic patients develop one or several of these neuropathies within 25 years after the diagnosis.
Y. Harati
semanticscholar +1 more source
Cranial neuralgias: from physiopathology to pharmacological treatment [PDF]
, 2008 Cranial neuralgias are paroxysmal painful disorders of the head characterised by some shared features such as unilaterality of symptoms, transience and recurrence of attacks, superficial and "shock-like" quality of pain and the presence of triggering ...
BILO, LEONILDA +4 more
core +1 more source
Artificial Intelligence and Diabetes Mellitus: An Inside Look Through the Retina [PDF]
Diabetes mellitus (DM) predisposes patients to vascular complications. Retinal images and vasculature reflect the body's micro- and macrovascular health. They can be used to diagnose DM complications, including diabetic retinopathy (DR), neuropathy, nephropathy, and atherosclerotic cardiovascular disease, as well as forecast the risk of cardiovascular ...
arxiv +1 more source